Waystar (NASDAQ:WAY) Hits New 1-Year Low – Time to Sell?

Shares of Waystar Holding Corp. (NASDAQ:WAY) reached a new 52-week low on Tuesday . The stock traded as low as $28.60 and last traded at $28.8050, with a volume of 300992 shares traded. The stock had previously closed at $29.57.

Analyst Upgrades and Downgrades

A number of research firms have commented on WAY. Needham & Company LLC started coverage on shares of Waystar in a report on Tuesday, November 11th. They issued a “buy” rating and a $46.00 price target for the company. Mizuho raised their target price on Waystar from $48.00 to $50.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. BMO Capital Markets assumed coverage on Waystar in a research note on Thursday, November 13th. They set an “outperform” rating and a $47.00 price target on the stock. Zacks Research lowered Waystar from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 1st. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Waystar in a report on Wednesday, January 21st. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $46.64.

Waystar Price Performance

The firm has a market cap of $5.48 billion, a P/E ratio of 46.08, a price-to-earnings-growth ratio of 0.37 and a beta of 0.76. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.89 and a quick ratio of 3.89. The firm’s 50 day moving average is $32.95 and its 200 day moving average is $35.57.

Insiders Place Their Bets

In related news, CMO Melissa F. (Missy) Miller sold 3,400 shares of the company’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $37.00, for a total value of $125,800.00. Following the transaction, the chief marketing officer owned 193,261 shares in the company, valued at $7,150,657. The trade was a 1.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CTO Christopher L. Schremser sold 8,623 shares of the stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $30.41, for a total transaction of $262,225.43. Following the sale, the chief technology officer directly owned 422,371 shares in the company, valued at $12,844,302.11. This trade represents a 2.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 80,273 shares of company stock valued at $2,569,997. 4.10% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in WAY. Salomon & Ludwin LLC bought a new stake in Waystar in the 3rd quarter worth approximately $25,000. ANTIPODES PARTNERS Ltd lifted its holdings in Waystar by 120.1% in the third quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock valued at $31,000 after acquiring an additional 449 shares during the period. First Horizon Corp purchased a new position in Waystar in the third quarter worth about $38,000. Nisa Investment Advisors LLC grew its stake in shares of Waystar by 50.6% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,065 shares of the company’s stock valued at $44,000 after purchasing an additional 358 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in shares of Waystar by 3,219.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock valued at $57,000 after purchasing an additional 1,352 shares during the last quarter.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.